EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Survival Advantage Comparing Older Living Donor Versus Standard Criteria Donor Kidney Transplants

Kamlesh Patel, Anna Brotherton, Daoud Chaudhry, Felicity Evison, Thomas Nieto, Dilan Dabare, Adnan Sharif

Transplant International · 2024

DOI: 10.3389/ti.2024.12559 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Transplant International, 2024. Verfasst von Kamlesh Patel und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nephrology and Transplantation, University Hospitals Birmingham, Birmingham, United Kingdom. Hauptthemen laut MEDLINE: Kidney Transplantation, Kidney Failure, Chronic. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The aim of this analysis was to explore mortality outcomes for kidney transplant candidates receiving older living donor kidneys (age ≥60 years) versus younger deceased donors or remaining on dialysis. From 2000 to 2019, all patients on dialysis listed for their first kidney-alone transplant were included in a retrospective cohort analysis of UK transplant registry data. The primary outcome was all-cause mortality, with survival analysis conducted by intention-to-treat principle. Time-to-death from listing was modelled using nonproportional hazard Cox regression models with transplantation handled as a time-dependent covariate. A total of 32,978 waitlisted kidney failure patients formed the primary study cohort, of whom 18,796 (58.5%) received a kidney transplant (1,557 older living donor kidneys and 18,062 standard criteria donor kidneys). Older living donor kidney transplantation constituted only 17.0% of all living donor kidney transplant activity (overall cohort; n = 9,140). Recipients of older living donor kidneys had reduced all-cause mortality compared to receiving SCD kidneys (HR 0.904, 95% CI 0.845–0.967, p = 0.003) and much lower all-cause mortality versus remaining on the waiting list (HR 0.160, 95% CI 0.149–0.172, p < 0.001). Older living kidney donors should be actively explored to expand the living donor kidney pool and are an excellent treatment option for waitlisted kidney transplant candidates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationKidney Failure, ChronicHumansMiddle AgedLiving DonorsRetrospective StudiesTissue DonorsKidneyGraft Survival

Stichwörter der Autor:innen

kidney transplantationmortalityolder living donorstandard criteria donorsurvival

Autor:innen und Institutionen

  • Department of Nephrology and Transplantation, University Hospitals Birmingham, Birmingham, United Kingdom.
  • School of Medical and Dental Sciences, University of Birmingham, Birmingham, United Kingdom.
  • Data Science Team, Research Development and Innovation, University Hospitals Birmingham, Birmingham, United Kingdom.
  • Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.

Zitieren

APA

Patel, K., Brotherton, A., Chaudhry, D., Evison, F., Nieto, T., Dabare, D., & Sharif, A. (2024). Survival Advantage Comparing Older Living Donor Versus Standard Criteria Donor Kidney Transplants. Transplant International. https://doi.org/10.3389/ti.2024.12559

Vancouver

Patel K, Brotherton A, Chaudhry D, Evison F, Nieto T, Dabare D, et al. Survival Advantage Comparing Older Living Donor Versus Standard Criteria Donor Kidney Transplants. Transplant International. 2024. doi:10.3389/ti.2024.12559

BibTeX
@article{Patel2024,
  author = {Patel, Kamlesh and Brotherton, Anna and Chaudhry, Daoud and Evison, Felicity and Nieto, Thomas and Dabare, Dilan and Sharif, Adnan},
  title = {Survival Advantage Comparing Older Living Donor Versus Standard Criteria Donor Kidney Transplants},
  journal = {Transplant International},
  year = {2024},
  doi = {10.3389/ti.2024.12559}
}
Kostenlos starten →